Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axogen Inc 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 USA

www.axogeninc.com Employees: 452 P: 386-462-6800 F: 386-462-6801

Sector:

Medical

Description:

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,510,034
Enterprise Value, $K 1,523,984
Shares Outstanding, K 46,122
Annual Sales, $ 187,340 K
Annual Net Income, $ -9,960 K
Last Quarter Sales, $ 60,080 K
Last Quarter Net Income, $ 710 K
EBIT, $ 3,940 K
EBITDA, $ 12,670 K
60-Month Beta 1.06
% of Insider Shareholders 2.78%
% of Institutional Shareholders 80.29%
Float, K 44,840
% Float 97.22%
Short Interest 2,849
Short Float 6.18%
Short Volume Ratio 0.46

Growth:

1-Year Return 86.27%
3-Year Return 228.06%
5-Year Return 82.91%
5-Year Revenue Growth 75.56%
5-Year Earnings Growth 66.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.12 on 10/29/25
Next Earnings Date 02/24/26
Earnings Per Share ttm -0.05
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 125.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 1.000 on 01/27/10
Dividend Payable Date 02/12/10
Dividend Payout Ratio 0.00%

AXGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1.90%
Return-on-Assets % -1.02%
Profit Margin % -5.32%
Debt/Equity 0.40
Price/Sales 7.87
Price/Cash Flow N/A
Price/Book 12.21
Book Value/Share 2.62
Interest Coverage -0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar